Anpario forecasts 23% FY 2025 revenue growth
Asia expansion and Bio-Vet boost earnings outlook
20 January 2026
1 minute read
By: UK animal feed additive maker Anpario said it expects full-year 2025 revenue to rise 23% year over year, driven by strong growth in its Asia segment and a full-year contribution from its Bio-Vet acquisition, according to a Reuters report published Monday.
The company estimated FY 2025 revenue at £47.10 million, beating market expectations of £45.75 million based on two analysts. Anpario said adjusted EBITDA for the year is also expected to exceed market expectations, citing high operational gearing.
Anpario said the Bio-Vet acquisition made a full-year contribution to revenue and performance in FY 2025, and confirmed it has completed the final payment related to the deal.
The company did not provide specific guidance for future quarters or years.
The single analyst covering Anpario rates the shares a “buy,” in line with the average consensus recommendation for the fishing and farming peer group. Wall Street’s median 12-month price target for Anpario PLC is 558.50 pence, about 17.6% above the Jan. 16 closing price of 475.00 pence.
Anpario shares recently traded at about 13 times expected earnings over the next 12 months, down from a price-to-earnings ratio of 15 three months ago.
